Findings validate the use of mHealth technologies in cardiovascular treatment NEW YORK, March 19, 2019 /PRNewswire/ — Koneksa Health, a private company that enables the biopharmaceutical industry to develop new...
Read More
Findings demonstrate the importance of analytical and clinical evaluation in the applicability of wearable devices in R&D NEW YORK, Feb. 5, 2019 /PRNewswire/ — Koneksa Health, a private company that enables...
Read More
Chris Benko Presented on Using Wearable Technology in Clinical Trials NEW YORK, Jan. 29, 2019 /PRNewswire/ — Koneksa Health, a private company that enables the biopharmaceutical industry to develop...
Read More
Renowned oncologist William A. Wood, MD, MPH, of UNC Lineberger joins scientific advisors NEW YORK, Jan. 8, 2019 /PRNewswire/ — Koneksa Health, a private company that enables the biopharmaceutical...
Read More
Validating Remote FEV1 Monitoring in Moderate Asthmatics to Increase Study Power NEW YORK (PRWEB) MAY 21, 2018 Koneksa Health, an early-stage company focused on the integration of real-world data...
Read More
Koneksa Health enables oncology research at Montefiore Einstein Center for Cancer Care by facilitating the collection and visualization of activity data from Garmin vivofit® devices. NEW YORK, NY (PRWEB)...
Read More
CAMBRIDGE, Mass. & NEW YORK–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) and Koneksa Health, Inc. (“Koneksa”), an early stage company focused on the integration of real world data into clinical research,...
Read More
